Locking catheters with trisodium citrate reduces infection during hemodialysis
Rebecca Doherty
This article has no abstract so we have provided the first paragraph of the full text.
Catheter use in hemodialysis can lead to infection and reduced blood flow caused by coagulation; heparin has traditionally been used to maintain catheter patency but can cause systemic anticoagulation and persistent bleeding. Weijmer and colleagues compared heparin with trisodium citrate (TSC), a local anticoagulant with antimicrobial properties, for use in catheter locking. Their multicenter, double-blind, randomized, controlled trial has demonstrated that using TSC rather than heparin to lock catheters during hemodialysis for end-stage renal disease leads to a reduction in catheter-related bacteremia (CRB) and other complications.
Full text of this article is available with one of the following:
- Membership of the International Society of Nephrology. If already a member, please login. If not please join the Society now
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please login for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or login above.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
